CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 8 enrolled
Drug / intervention
Milnacipramdrug
Likely dose
Milnacipram 200mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01288807
NCT01288807Phase 4Completed
CompareCT.gov

Effects of a 12 Week Milnacipran 200 mg Treatment on Pain Perception and Pain Processing in Fibromyalgia - An Open Label Study

University of California, San Diego·interventional·Posted Feb 2, 2011·Updated Sep 24, 2019

In Brief

A Phase 4 clinical trial evaluating Milnacipram for Fibromyalgia. Completed, enrolled 8 participants across 1 site.

Detailed Summary

The investigators want to study the effects of milnacipran treatment on neurotransmitter release in fibromyalgia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFibromyalgia
CountriesUnited States
CollaboratorsForest Laboratories, US Department of Veterans Affairs

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2, 2011
Enrollment StartFeb 1, 2011
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 15.4 years ago

Interventions

Milnacipramdrug

Titration to 200mg PO daily